3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Motor Activity
30
Breast Neoplasms
19
Neoplasms
13
Prostatic Neoplasms
10
Obesity
6
Colorectal Neoplasms
6
Sarcopenia
5
Pancreatic Neoplasms
5
Lung Neoplasms
4
Signs and Symptoms
3
Polycystic Ovary Syndrome
3
Multiple Myeloma
3
Lymphedema
3
Inflammation
3
Head and Neck Neoplasms
3
Fatigue
3
Diabetes Mellitus, Type 2
3
Colonic Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Neoplasms
2
Osteoporosis, Postmenopausal
2
Osteoporosis
2
Lymphoma
2
Leukemia
2
Diabetes Mellitus
2
Carcinoma, Non-Small-Cell Lung
2
Cachexia
2
Weight Loss
1
Uterine Neoplasms
1
Urinary Incontinence
1
Interventions
fludarabine phosphate
10
Cyclophosphamide
10
Peripheral Blood Stem Cell Transplantation
9
Cyclosporine
7
Mycophenolic Acid
6
Filgrastim
6
Antilymphocyte Serum
6
Whole-Body Irradiation
5
Busulfan
5
Radiotherapy
4
Psychiatric Rehabilitation
4
Cytarabine
4
Methylprednisolone
3
Methotrexate
3
Melphalan
3
Cord Blood Stem Cell Transplantation
3
Aprepitant
3
thymoglobulin
2
Therapeutics
2
Tacrolimus
2
Polymerase Chain Reaction
2
Ondansetron
2
Mesna
2
Flow Cytometry
2
Dexamethasone
2
Calcium Dobesilate
2
Analgesia
2
sargramostim
1
plerixafor
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Myeloproliferative Disorders
×
Resistance Training
×
Clear all
NCT07518940
2026-04-09
ENERGIA
University of Turin, Italy
Phase NA
Not yet recruiting
25 enrolled